Structure via PubChem · Public domain (PubChem)
methotrexate
Sign in to saveAlso known as amethopterin, 4-amino-10-methylfolic acid, 4-amino-N(10)-methylpteroylglutamic acid, MTX, N-(4-{[(2,4-diamino-6-pteridinyl)methyl]methylamino}benzoyl)-L-glutamic acid
Methotrexate, formerly known as amethopterin, is a chemotherapy agent and immune-system suppressant. It is used to treat cancer, autoimmune diseases, and ectopic pregnancies. Types of cancers it is used for include breast cancer, leukemia, lung cancer, lymphoma, gestational trophoblastic disease, and osteosarcoma. Types of autoimmune diseases it is used for include psoriasis, rheumatoid arthritis, and Crohn's disease. It can be given by mouth or by injection.
Key facts
- Drug.legal_status
- Rx-only
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 464193974
- Drug.image
- Methotrexate skeletal.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 300
- Drug.image2
- Methotrexate-from-xtal-3D-bs-17.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 300
- Drug.tradename
- Trexall, Rheumatrex, Otrexup, others
- Drug.MedlinePlus
- a682019
- Drug.DailyMedID
- Methotrexate
- Drug.pregnancy_AU
- D
- Drug.routes_of_administration
- By mouth, intravenous, intramuscular, subcutaneous, intrathecal
- Drug.ATC_prefix
- L01
- Drug.ATC_suffix
- BA01
- Drug.legal_AU
- S4
- Drug.legal_CA
- Rx-only
via Wikipedia infobox
Chemical data
- Formula
- C20H22N8O5
- Molecular weight
- 454.4 g/mol
- IUPAC name
- (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid
- SMILES
- CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
- InChIKey
- FBOZXECLQNJBKD-ZDUSSCGKSA-N
- XLogP
- -1.8
- Polar surface area
- 211 Ų
- H-bond donors
- 5
- H-bond acceptors
- 12
- Formal charge
- 0
via PubChem
Research
66,595 papers- The mechanism of action of methotrexate.Rheumatic diseases clinics of North America · 1997
- Methotrexate polyglutamates.Expert review of clinical pharmacology · 2024
- Molecular mechanism of action and pharmacokinetic properties of methotrexate.Molecular biology reports · 2020
- Methotrexate therapy.Canadian journal of gastroenterology = Journal canadien de gastroenterologie · 1998
- Methotrexate: Use in the Post Dobbs v. Jackson Era.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases · 2024
via PubMed
Wikidata facts
- Mass
- 454.171
Show 6 more facts
- canonical SMILES
- CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O
- chemical formula
- C₂₀H₂₂N₈O₅
- isomeric SMILES
- CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
- World Health Organisation international non-proprietary name
- methotrexate
- Commons category
- Methotrexate
- defined daily dose
- 2.5
Sources (8)
via Wikidata · CC0
~15 min read
Article
13 sectionsContents
- Medical uses
- Chemotherapy
- Autoimmune disorders
- Atopic dermatitis
- During pregnancy
- Administration
- Adverse effects
- Drug interactions
- Vaccine interactions
- Mechanism of action
- History
- References
- External links
{{Infobox drug | Watchedfields = changed | verifiedrevid = 464193974 | image = Methotrexate skeletal.svg | image_class = skin-invert-image | width = 300 | alt = | image2 = Methotrexate-from-xtal-3D-bs-17.png | image_class2 = bg-transparent | width2 = 300 | alt2 =
| pronounce = | tradename = Trexall, Rheumatrex, Otrexup, others | Drugs.com = | MedlinePlus = a682019 | DailyMedID = Methotrexate | pregnancy_AU = D | routes_of_administration = By mouth, intravenous, intramuscular, subcutaneous, intrathecal | ATC_prefix = L01 | ATC_suffix = BA01 | ATC_supplemental =